BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of over 1000 found
  Current Search:  pharma: 5053, pharmaceut: 21232     

HTML
100%
EUSA Pharma Completes Acquisition Of Cytogen Corporation
DOYLESTOWN, Pennsylvania and OXFORD, England, May 9 /PRNewswire/ -- EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has...
Financials.com:  May 9 2008 1:44PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
EUSA Pharma Completes Acquisition Of Cytogen Corporation
DOYLESTOWN, PA and OXFORD, England, May 9 /CNW/ - EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has completed its...
Globe Investor:  May 9 2008 10:04AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
EUSA Pharma Completes Acquisition Of Cytogen Corporation
DOYLESTOWN, PA and OXFORD, England, May 9 /CNW/ - EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has completed its...
Yahoo! Canada:  May 9 2008 9:45AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Dalton Pharma Services Licenses Thermo Fisher Scientific Technology to Produce Polynucleotides for Drug Develo
/PRNewswire/ - Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider, and Thermo Fisher Scientific have entered into an agreement under which Dalton will use a proprietary Thermo Fisher manufacturing...
Pharma Live:  May 9 2008 1:14PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Astellas Mycamine Licensed for Use in Europe
The European Medicines Agency (EMEA) has announced the marketing authorisation of Mycamine, Astellas Pharma Europes treatment for invasive candidiasis, oesophageal candidiasis and prophylaxis of Candida infection in patients undergoing...
Pharma Live:  May 9 2008 7:52PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Par Pharmaceutical Reports First Quarter 2008 Results
Reports First Quarter Adjusted EPS of $0.17 per Diluted Share Provides Full-year 2008 EPS Guidance and Projects its Pipeline Opportunities WOODCLIFF LAKE, N.J., May 8 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.

(NYSE...

PR Newswire via Yahoo!:  May 9 2008 12:19AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular De
LEVERKUSEN, Germany, MONTVILLE, New Jersey and TARRYTOWN, New York, May 08, 2008 /PRNewswire-FirstCall/ -- Bayer HealthCare AG and Regeneron Pharmaceuticals, Inc.

today announced that the first patient has been dosed in the VIEW 2...

Pharma Live:  May 9 2008 11:26AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
EUSA Pharma Completes Acquisition Of Cytogen Corporation
DOYLESTOWN, Pennsylvania and OXFORD, England, May 9 /PRNewswire/ -- EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has...
PR Newswire via Yahoo!:  May 9 2008 9:19AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Advent International Acquires LaborMed Pharma
Advent International, a leading global buyout firm, has completed the acquisition of LaborMed Pharma from its founders.

LaborMed, based in Bucharest, manufactures and distributes generic pharmaceuticals, primarily for...

Altana Pharma:  May 9 2008 10:44AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Ipsen: Adenuric (Febuxostat) Receives Marketing Authorisation in the European Union
- Regulatory News: Ipsen (Paris:IPN) today announced that the European Commission granted marketing authorisation for Adenuric(R) (febuxostat) for the treatment of chronic hyperuricaemia in gout.

Adenuric(R) thus pioneers the first major...

Pharma Live:  May 9 2008 7:55PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Sciele Pharma to Present at Bank of America Health Care Conference
The audio presentation is being broadcast on the Internet and may be accessed at the Company's website, www.sciele.com.

Sciele Pharma, Inc.

Background Sciele Pharma, Inc.

is a pharmaceutical company specializing in...

Pharma Live:  May 8 2008 11:28PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Get ready for a biotech buyout boom
Next week, I'm giving a speech at the 13th Annual Pharmaceutical and Biotech Licensing and Deal Making Summit.

To prepare for my presentation, I spoke to many of my hedge fund contacts.

Given that I'm already a biotech bull, I...

Money Week:  May 9 2008 2:02PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Takeda sees big profit slump on Millennium costs
Stocks mentioned in this article Amgen Inc (AMGN) Stock Quote, Chart, News, Add to Watchlist Millennium Pharmaceuticals Inc (MLNM) Stock Quote, Chart, News, Add to Watchlist TOKYO (Reuters) - Japan's Takeda Pharmaceutical Co Ltd...
Financial Times via MSN Money:  May 9 2008 7:49AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
EUSA Pharma Completes Acquisition Of Cytogen Corporation
, 1:07 AM EST Under the terms of the acquisition agreement, Cytogen shareholders will receive $0.62 Cytogen brings to EUSA three oncology and pain control products, a US specialty sales force and an established commercial infrastructure.
Genetic Engineering News:  May 9 2008 11:16AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
IDM Pharma Reports First Quarter Financial Results
IRVINE, Calif., May 8 /PRNewswire-FirstCall/ -- IDM Pharma, Inc.

(Nasdaq: IDMI - News) today reported financial results for the quarter ended March 31, 2008.

Financial information presented represents the consolidated results of...

Yahoo!:  May 8 2008 12:13PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Dalton Pharma Services Licenses Thermo Fisher Scientific Technology To Produce Polynucleotides For Drug Develo
Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider, and Thermo Fisher Scientific have entered into an agreement under which Dalton will use a proprietary Thermo Fisher manufacturing process to...
Pharmaceutical Online:  May 8 2008 10:50AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
LifeCycle Pharma Announces Positive Data From LCP-AtorFen Phase II Clinical Program
LifeCycle Pharma A/S announced recently positive results from the company's Phase II clinical program with LCP-AtorFen, a fixed-dose combination product of atorvastatin and fenofibrate for the treatment of mixed dyslipidemia.

LCP...

Pharmaceutical Online:  May 8 2008 10:50AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share
- Strong European and Rest of the World Sales - Proprietary Product Sales Increase, Portfolio Expanded - Company Provides Updated Adjusted Calendar 2008 EPS Guidance of $2.75 - $3.05 MONTVALE, N.J., May 8 /PRNewswire-FirstCall/ -- Barr ...
Yahoo! Canada:  May 8 2008 11:31AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Verticals onDemand Signs 15th Life Sciences Customer, Marking the Dawn of an Industry-Wide Conversion from Cli
- In the last nine months, fifteen life sciences companies have signed with Verticals onDemand, the pharmaceutical industry's only provider of Software-as-a-Service (SaaS) CRM solutions.

Verticals onDemand's latest customer, UK-based...

Pharma Live:  May 8 2008 2:18AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
The Maybach Journal: IDM Pharma Reports First Quarter Financial Results
(M2 PressWIRE Via Acquire Media NewsEdge) RDATE:08052008 MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world.

Investors wanting to know the truth about investing and how to consistently...

TMC Net:  May 8 2008 9:35PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Cytogen Reports First Quarter 2008 Financial Results
PRINCETON, N.J.--(BUSINESS WIRE)--Cytogen Corporation (NASDAQ: CYTO - News) today reported its financial results for the first quarter of 2008.

Cytogen reported a net loss of $5.9 million, or $0.16 per diluted share for the first quarter...

Yahoo!:  May 8 2008 12:13PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Par Pharmaceutical Reports First Quarter 2008 Results
WOODCLIFF LAKE, N.J., May 8 /PRNewswire-FirstCall/ -- Par Pharmaceutical (News) Companies, Inc.

today reported results for the first quarter ended March 29, 2008.

Par reported total revenues of $154.9 million and net income of $2.6...

FinanzNachrichten.de:  May 8 2008 10:08PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Par Pharmaceutical Reports First Quarter 2008 Results
Reports First Quarter Adjusted EPS of $0.17 per Diluted Share Provides Full-year 2008 EPS Guidance and Projects its Pipeline Opportunities WOODCLIFF LAKE, N.J., May 8 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.

(NYSE...

Yahoo! Canada:  May 8 2008 9:36PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Amneal Pharmaceuticals Receives US FDA Approval For Three Generic Prescription Drugs; Two Using New FDA Electr
Amneal Pharmaceuticals is pleased to announce that it received US FDA approval to manufacture Primidone Tablets (50/250mg), Cyclobenzaprine Tablets (10mg) and Demeclocycline Tablets (150/300mg) within the last several weeks.

Two of...

Pharmaceutical Online:  May 8 2008 10:50AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
S&P: Royalty Pharma's Proposed $300M Unsecured Term Loan Rated 'BB+'
-Standard & Poor's Ratings Services today assigned its 'BB+' rating to Royalty Pharma Finance Trust's proposed $300 million senior unsecured term loan due 2015.

Proceeds will be used to fund the company's future acquisitions.

Pharma Live:  May 7 2008 11:55PM
Matching: pharma pharmaceut
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.